TWO DOSES OF DEXMEDETOMIDINE AS AN ADJUVANT TO INTRATHECAL HYPERBARIC ROPIVACAINE.
Phase 4
- Conditions
- Health Condition 1: M810- Age-related osteoporosis without current pathological fractureHealth Condition 2: O- Medical and SurgicalHealth Condition 3: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2023/05/052743
- Lead Sponsor
- CHANDINI MISHRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.American society of Anaesthesiologist (ASA) Physical Status I and II posted for
elective lower limb surgeries.
2.Patients of age 18-60 years of either sex.
Exclusion Criteria
1.History of allergy to the drugs used in the study like ropivacaine,dexmedetomidine.
2.pregnant women
3.deformity in spine.
4.patients with sinus bradycardia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢. Postoperative VAS score. <br/ ><br>Timepoint: 2,4,6,8,12 hours <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.The incidence of hypotension and bradycardia intraoperatively. <br/ ><br>2. Time taken for onset of sensory component by using the cold swab test till the <br/ ><br>loss of sensations.Timepoint: 2HRS,4HRS,6HRS,12HRS.